Precision Radiotherapy for Gliomas: Implementing Novel Imaging Biomarkers to Improve Outcomes With Patient-Specific Therapy. Issue 5 (September 2021)

• Record Type: Journal Article
• Authors: Connor, Michael; Kim, Michelle M.; Cao, Yue; Hattangadi-Gluth, Jona
• Is Part Of: Cancer journal. Volume 27:Issue 5(2021)
• Page Start: 353
• Page End: 363
• Publication Date: 2021-09
• Subjects: Diffusion MRI -- glioblastoma -- glioma -- MRI -- neurocognitive -- PET; Cancer -- Periodicals; 616.994005
• DOI: 10.1097/PPO.0000000000000546
• Languages: English
• ISSNs: 1528-9117

Abstract

Abstract: Gliomas are the most common primary brain cancer, yet are extraordinarily challenging to treat because they can be aggressive and infiltrative, locally recurrent, and resistant to standard treatments. Furthermore, the treatments themselves, including radiation therapy, can affect patients' neurocognitive function and quality of life. Noninvasive imaging is the standard of care for primary brain tumors, including diagnosis, treatment planning, and monitoring for treatment response. This article explores the ways in which advanced imaging has and will continue to transform radiation treatment for patients with gliomas, with a focus on cognitive preservation and novel biomarkers, as well as precision radiotherapy and treatment adaptation. Advances in novel imaging techniques continue to push the field forward, to more precisely guided treatment planning, radiation dose escalation, measurement of therapeutic response, and understanding of radiation-associated injury.